| Today's Open | $20.30 |
|---|---|
| Previous Close | $20.16 |
| Daily Range | $20.07 - $20.75 |
| 52-Week Range | $7.56 - $23.03 |
| Market Cap | $2.1B |
| P/E Ratio | -46.88 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,729,851 |
| Average Daily Volume | 1,778,355 |
| Current FY EPS | -$0.86 |
Sector
Healthcare
Industry
Drugs
ISIS Pharmaceuticals, Inc. (ISIS) Description
The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/
News & Commentary
Presentation Pandemonium = 30% Pop
Why shares of Aegerion soared more than 30% today.ISIS Pharmaceuticals Management Presents at Bank of America Merrill Lynch Health Care Conference (Tr
ISIS Pharmaceuticals Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)1 Biotech's Surprise Dilution Decoded
Isis Pharmaceuticals gives biotech investors a painful reminder that dilution can come when they least expect it.3 Horrendous Health-Care Stocks This Week
These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.ISIS's Top Competitors
(2.48%)
(0.63%)
(2.44%)
(-0.50%)